< back to search

A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis.

Inman, Robert D   •   Maksymowych, Walter P

published in: The Journal of rheumatology



endpoint

Infliximab has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection therapy
conservative therapy → injection

publication details

10.3899/jrheum.091042
pubmed
20231198
2010
randomized controlled trial
yes
prospective
1+

▼
▲